Reversible white matter changes following a 4‐week high phenylalanine exposure in adults with phenylketonuria

Documenti analoghi

• Brain Age in Adult Patients With Early‐Treated Phenylketonuria
  di: Laura Winiger, et al.
  Pubblicazione: (2026)
• A phenylalanine‐free recombinant nutritional protein for the dietary management of phenylketonuria
  di: Yvonne Mücke, et al.
  Pubblicazione: (2024)
• The clinical relevance of novel biomarkers as outcome parameter in adults with phenylketonuria
  di: A. M. J. van Wegberg, et al.
  Pubblicazione: (2024)
• Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l‐amino acid‐based product
  di: Abrar Turki, et al.
  Pubblicazione: (2024)
• Genetically humanized phenylketonuria mouse model as a testing tool for human genome editing in fertilized eggs
  di: Atsumi Tsuji‐Hosokawa, et al.
  Pubblicazione: (2024)